Facet Biotech Announces Participation at the BMO Capital Markets 9th Annual Focus on Healthcare Conference and Webcast
* Reuters is not responsible for the content in this press release.
REDWOOD CITY, CA, Jul 30 (MARKET WIRE) --
Facet Biotech Corporation (NASDAQ: FACT) today announced that the company
will participate at the upcoming BMO Capital Markets 9th Annual Focus on
Healthcare Conference in New York on Wednesday, August 5, 2009 at 8:30
a.m., Eastern Time.
A live webcast of the presentation and the Q&A session will be available
through the Facet website at www.facetbiotech.com. Please connect to this
website at least 15 minutes prior to the live webcast to allow time for
any software download that may be needed to hear the webcast. A replay
will be available at www.facetbiotech.com starting approximately one hour
after completion of the webcast.
About Facet Biotech
Facet Biotech is a biotechnology company dedicated to advancing its
pipeline of four clinical-stage products, leveraging its research and
development capabilities to identify and develop new oncology drugs and
applying its proprietary next-generation protein engineering technologies
to potentially improve the clinical performance of protein therapeutics.
Facet Biotech Corporation launched in December 2008 as a spin-off from PDL
BioPharma, Inc.
NOTE: Facet Biotech and the Facet Biotech logo are considered trademarks
of Facet Biotech Corporation.
Contact:
Jean Suzuki
Investor Relations
(650) 454-2648
jean.suzuki@facetbiotech.com
Copyright 2009, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters